Ischemic Stroke Damage Reduced by Inter-α Inhibitor Proteins

Stroke is the primary cause of long-term adult disability and the fifth-leading cause of mortality in the U.S. Researchers at the University of Texas Health Science Center at Houston demonstrate post-stroke administration of IAIP protein family significantly improved stroke outcomes across multiple stroke models.